Jiazheng Ma

发表

An optimal window of platelet reactivity by LTA assay for patients undergoing percutaneous coronary intervention

Xiaofeng Zhang, Xiaoxuan Gong, Chunjian Li, 2021, Thrombosis Journal.

MicroRNA-210-5p alleviates cardiac fibrosis via targeting transforming growth factor-beta type I receptor in rats on high sodium chloride (NaCl)-based diet.

Kun Zhao, Yong Li, Litao Sun, 2021, European journal of pharmacology.

Effects of ilaprazole on the steady-state pharmacodynamics of clopidogrel in healthy volunteers: An open-label randomized crossover study

Zhuanxia Zhang, Feng Shao, Juan Chen, 2022, Frontiers in Pharmacology.

An optimal window of platelet reactivity by LTA assay for patients undergoing percutaneous coronary intervention

Xiaofeng Zhang, Xiaoxuan Gong, Chunjian Li, 2021, Thrombosis Journal.

Efficacy of an adjusted treatment strategy on the management and in-hospital outcome of patients with STEMI during the COVID-19 pandemic

Xiaoxuan Gong, Chunjian Li, Jianzhen Teng, 2022, Journal of biomedical research.

Use of handheld electrocardiograph (SnapECG) for the remote monitoring of arrhythmias

Yaqing Zhou, Ran Li, Xiaoxuan Gong, 2022, Digital health.

MicroRNA-133b alleviates doxorubicin-induced cardiomyocyte apoptosis and cardiac fibrosis by targeting PTBP1 and TAGLN2

Xiaoxuan Gong, Jianzhen Teng, Jiazheng Ma, 2021, International journal of molecular medicine.

Single Bolus r-SAK Before Primary PCI for ST-Segment–Elevation Myocardial Infarction

Xiaomei Zhu, Jiaxin Zong, Xiaoxuan Gong, 2024, Circulation. Cardiovascular interventions.

MicroRNA ‐ 133 b alleviates doxorubicin ‐ induced cardiomyocyte apoptosis and cardiac fibrosis by targeting PTBP 1 and TAGLN 2

Guangyu Qian, J. Teng, Lixiao Zhen, 2021 .